The Biofeedback Measurement Instrument Market, estimated at USD 207.5 Mn in 2025, is expected to exhibit a CAGR of 5.9% and reach USD 309.9 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
To bring patient-centered, high-quality care to more communities, the various market players are engaged in adoption of growth strategies, which is expected to offer significant growth opportunities for players in the global biofeedback measurement instrument market, on January 6, 2025, Thought Technology helped athletes to reach peak performance with biofeedback. Using the biological data, one can receive treatment for stress management. They will observe the indications return to normal when their bodies warm up or as their muscles relax.
Global biofeedback measurement instrument Market – Impact of Coronavirus (COVID-19) Pandemic
Since the outbreak of the COVID-19 pandemic in December 2025, the disease has spread to more than 100 countries worldwide and has been declared a public health emergency by the World Health Organization. The emergence of the coronavirus (COVID-19) had claimed more than 27 million lives worldwide, according to a report by the World Health Organization. The COVID pandemic has changed the homeostasis of the medical world and is affecting millions of people worldwide. The global crisis has consequences for the world economy in addition to health. On November 21, 2025 an article published by National Center for Biotechnology Information, explained Long COVID (LC), commonly referred to as post-COVID-19 syndrome, is a group of symptoms that last for more than 12 weeks following COVID-19 infection. It can produce a wide range of symptoms, such as fatigue, dyspnea, palpitations, dizziness, discomfort, and brain fog, and can affect up to one in seven persons who get the sickness. After SARS-CoV2 infection, many of these symptoms can be attributed to dysautonomia, or the dysfunction of the autonomic nerve system. Through a standardised slow diaphragmatic breathing practise, this study seeks to assess the feasibility and usefulness of the heart rate variability biofeedback (HRV-B) technique in people with LC.
Global biofeedback measurement instrument Market: Key Developments
On January 24, 2025, Thought Technology, a psychophysiological monitoring equipment declared their partnership with Piiva, which will see the inclusion of Thought Tech's GSR2 biofeedback equipment in Piiva's flagship programme, Piiva Elite. The GSR2 translates minute tension-related changes in skin pores caused by stress into a rising or decreasing tone, allowing users to track their levels of stress. The first step in learning how to control the stress reaction and achieve a state of inner calmness is understanding how one's body responds to stress.